Payment overview · 2025
General Payments
$16.23
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robert D Wigert, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SPOKANE, WA · NPI 1215994587
Verified facts
What the public records show
CMS Open Payments records show Robert D Wigert, MD received $16.23 in general payments during 2025 across 1 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $16.23 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.23 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $16.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 940 | 255 |
| Losartan Potassium | Losartan Potassium | 559 | 157 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 508 | 77 |
| Lisinopril | Lisinopril | 497 | 123 |
| Potassium Chloride | Potassium Chloride | 457 | 100 |
| Amlodipine Besylate | Amlodipine Besylate | 417 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 405 | 103 |
| Gabapentin | Gabapentin | 400 | 85 |
| Omeprazole | Omeprazole | 357 | 94 |
| Bupropion Xl | Bupropion Hcl | 333 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 333 | 89 |
| Furosemide | Furosemide | 275 | 58 |
| Trazodone Hcl | Trazodone Hcl | 273 | 57 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 263 | 76 |
| Metformin Hcl | Metformin Hcl | 256 | 67 |
| Eliquis | Apixaban | 248 | 47 |
| Allopurinol | Allopurinol | 234 | 53 |
| Duloxetine Hcl | Duloxetine Hcl | 229 | 49 |
| Mirtazapine | Mirtazapine | 219 | 35 |
| Simvastatin | Simvastatin | 210 | 53 |
| Hydrochlorothiazide | Hydrochlorothiazide | 205 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 197 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 187 | 58 |
| Citalopram Hbr | Citalopram Hydrobromide | 179 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 173 | 50 |
| Montelukast Sodium | Montelukast Sodium | 153 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 147 | 50 |
| Lorazepam | Lorazepam | 141 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 131 | 30 |
| Jardiance | Empagliflozin | 129 | 27 |
| Sertraline Hcl | Sertraline Hcl | 128 | 34 |
| Alprazolam | Alprazolam | 126 | 26 |
| Metformin Hcl Er | Metformin Hcl | 123 | 28 |
| Prednisone | Prednisone | 121 | 69 |
| Quetiapine Fumarate | Quetiapine Fumarate | 120 | 17 |
| Spironolactone | Spironolactone | 117 | 28 |
| Buspirone Hcl | Buspirone Hcl | 112 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 104 | 30 |
| Baclofen | Baclofen | 101 | 32 |
| Famotidine | Famotidine | 100 | 22 |
| Alendronate Sodium | Alendronate Sodium | 99 | 26 |
| Ezetimibe | Ezetimibe | 98 | 27 |
| Oxycodone Hcl | Oxycodone Hcl | 98 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 91 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 88 | 14 |
| Aripiprazole | Aripiprazole | 85 | 12 |
| Clonazepam | Clonazepam | 85 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 84 | 25 |
| Estradiol | Estradiol | 84 | 29 |
| Glipizide | Glipizide | 84 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 83 | 21 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 83 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 80 | 19 |
| Synthroid | Levothyroxine Sodium | 78 | 15 |
| Methadone Hcl | Methadone Hcl | 76 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 74 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 20 |
| Donepezil Hcl | Donepezil Hcl | 73 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 71 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 70 | 57 |
| Ondansetron Odt | Ondansetron | 70 | 15 |
| Sucralfate | Sucralfate | 70 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 67 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 19 |
| Ozempic | Semaglutide | 66 | 16 |
| Tramadol Hcl | Tramadol Hcl | 66 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 65 | 18 |
| Naproxen | Naproxen | 65 | 21 |
| Xarelto | Rivaroxaban | 61 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 57 | suppressed |
| Fentanyl | Fentanyl | 57 | suppressed |
| Acyclovir | Acyclovir | 56 | 20 |
| Imipramine Hcl | Imipramine Hcl | 50 | suppressed |
| Methylprednisolone | Methylprednisolone | 50 | 45 |
| Carvedilol | Carvedilol | 49 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | 13 |
| Methocarbamol | Methocarbamol | 49 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 49 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 48 | 12 |
| Diazepam | Diazepam | 46 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 46 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | 14 |
| Azithromycin | Azithromycin | 42 | 31 |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | suppressed |
| Celecoxib | Celecoxib | 40 | 12 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 39 | suppressed |
| Chlorthalidone | Chlorthalidone | 38 | 11 |
| Fenofibrate | Fenofibrate | 37 | suppressed |
| Topiramate | Topiramate | 37 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 36 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 35 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | 11 |
| Atenolol | Atenolol | 33 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 33 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 32 | suppressed |
| Ketoconazole | Ketoconazole | 31 | suppressed |
| Memantine Hcl | Memantine Hcl | 30 | suppressed |
| Torsemide | Torsemide | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Meloxicam | Meloxicam | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 24 |
| Cephalexin | Cephalexin | 28 | 25 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Gemfibrozil | Gemfibrozil | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 15 |
| Fluconazole | Fluconazole | 26 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 19 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 13 |
| Estradiol (Once Weekly) | Estradiol | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 17 |
| Valacyclovir | Valacyclovir Hcl | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 22 | suppressed |
| Telmisartan | Telmisartan | 22 | suppressed |
| Testosterone | Testosterone | 22 | suppressed |
| Oxycontin | Oxycodone Hcl | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 16 |
| Irbesartan | Irbesartan | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 18 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Finasteride | Finasteride | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | 12 |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 15 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Dexmethylphenidate Hcl | Dexmethylphenidate Hcl | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.23 · 1 records | GlaxoSmithKline, LLC. | SHINGRIX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error